VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Oracle Corporation vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Oracle Corporation
ORCL · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Oracle Corporation's moat claims, evidence, and risks.
View ORCL analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 56 / 100 for Oracle Corporation).
- Segment focus: Oracle Corporation has 5 segments (42.9% in Infrastructure cloud services and license support); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: Oracle Corporation has 7 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Oracle Corporation
Infrastructure cloud services and license support
Enterprise cloud infrastructure services (IaaS/PaaS, cloud database) plus related support
Global
Enterprises & developers
Cloud service provider (IaaS/PaaS)
42.9%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Oracle Corporation strengths
Sanofi strengths
Segment mix
Oracle Corporation segments
Full profile >Applications cloud services and license support
Oligopoly
Infrastructure cloud services and license support
Oligopoly
Cloud license and on-premise license
Oligopoly
Hardware
Competitive
Services
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.